Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID ▼ | Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BB01 |
|
44260828 | 2249.130161 | C100H176N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BB00 |
|
GSG1398 | |||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA08 |
|
44260827 | 2241.213101 | C104H184N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA07 |
|
44260826 | 2213.181801 | C102H180N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA06 |
|
44260825 | 2243.228751 | C104H186N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA05 |
|
44260824 | 2215.197451 | C102H182N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA04 |
|
44260823 | 2187.166151 | C100H178N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA03 |
|
44260822 | 2159.134851 | C98H174N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA02 |
|
44260821 | 2131.103551 | C96H170N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA01 |
|
44260820 | 2103.072251 | C94H166N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BA00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ08 |
|
44260819 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ07 |
|
44260818 | 2359.239711 | C108H190N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ06 |
|
44260817 | 2389.286661 | C110H196N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ05 |
|
44260816 | 2361.255361 | C108H192N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ04 |
|
44260815 | 2333.224061 | C106H188N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ03 |
|
44260814 | 2305.192761 | C104H184N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ02 |
|
44260813 | 2277.161461 | C102H180N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ01 |
|
44260812 | 2249.130161 | C100H176N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ00 |
|
GSG1397 | |||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AY08 |
|
44260811 | 2241.213101 | C104H184N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AY07 |
|
44260810 | 2213.181801 | C102H180N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AY06 |
|
44260809 | 2243.228751 | C104H186N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AY05 |
|
44260808 | 2215.197451 | C102H182N4O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AY04 |
|
44260807 | 2187.166151 | C100H178N4O47 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024